<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     nad a22        4500</leader>
  <controlfield tag="001">569302854</controlfield>
  <controlfield tag="005">20190726063007.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">190726e201904  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.5167/uzh-171633</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s11789-019-00101-8</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(ZORA)oai:www.zora.uzh.ch:171633</subfield>
  </datafield>
  <datafield tag="084" ind1=" " ind2=" ">
   <subfield code="a">610</subfield>
   <subfield code="2">ddc</subfield>
  </datafield>
  <datafield tag="084" ind1=" " ind2=" ">
   <subfield code="a">540</subfield>
   <subfield code="2">ddc</subfield>
  </datafield>
  <datafield tag="091" ind1=" " ind2=" ">
   <subfield code="a">30838553</subfield>
   <subfield code="b">pmid</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
   <subfield code="a">Nave</subfield>
   <subfield code="D">Alexander Heinrich</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
   <subfield code="a">Is lipoprotein(a) arisk factor for ischemic stroke and venous thromboembolism?</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Alexander Heinrich Nave, Arnold von Eckardstein]</subfield>
  </datafield>
  <datafield tag="506" ind1=" " ind2=" ">
   <subfield code="a">openAccess</subfield>
   <subfield code="2">eu-repo</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">The structural similarity with plasminogen as well as thrombogenic and atherogenic in vitro functions raise the question if lipoprotein(a) (Lp(a)) is arisk factor for venous thromboembolism (VTE) and ischemic stroke. Numerous case-control and prospective studies using different cut-off values to define high Lp(a) generated conflicting evidence for both VTE and ischemic stroke. Several meta-analyses demonstrated independent associations of elevated Lp(a) with ahistory of VTE or ischemic stroke. However, the evidence of prospective studies for associations of Lp(a) with incident stroke or recurrent VTE remains inconclusive. For ischemic stroke, data suggest that Lp(a) increases the risk of large-artery atherosclerosis stroke, but not cardioembolic or lacunar stroke. Lp(a) may increase the risk of VTE in the presence of additional thrombophilic risk factors. Larger cohort studies are needed to elaborate the importance of higher Lp(a) cut-offs and interactions with other risk factors and subgroups of stroke or VTE. The value of Lp(a) to estimate residual vascular risk after the first thromboembolic event remains to be adequately explored.</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Institute of Clinical Chemistry</subfield>
   <subfield code="2">zora</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">von Eckardstein</subfield>
   <subfield code="D">Arnold</subfield>
   <subfield code="e">joint author</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Clinical Research in Cardiology Supplements</subfield>
   <subfield code="g">14(Suppl 1):28-32</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://www.zora.uzh.ch/id/eprint/171633/1/s11789-019-00101-8.pdf</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">WWW-Backlink auf das Repository</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">Journal Article</subfield>
   <subfield code="z">PeerReviewed</subfield>
   <subfield code="2">zora</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">ZORA</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://www.zora.uzh.ch/id/eprint/171633/1/s11789-019-00101-8.pdf</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">WWW-Backlink auf das Repository</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">ZORA</subfield>
   <subfield code="P">100</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Nave</subfield>
   <subfield code="D">Alexander Heinrich</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">ZORA</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">von Eckardstein</subfield>
   <subfield code="D">Arnold</subfield>
   <subfield code="e">joint author</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">ZORA</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Clinical Research in Cardiology Supplements</subfield>
   <subfield code="g">14(Suppl 1):28-32</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">ZORA</subfield>
   <subfield code="F">ZORA</subfield>
   <subfield code="b">ZORA</subfield>
   <subfield code="j">Journal Article</subfield>
   <subfield code="c">openAccess</subfield>
  </datafield>
 </record>
</collection>
